Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03976362 |
|---|---|
| Brief Title: | A Study of Pembrolizumab (MK-3475) With or Without Maintenance Olaparib in First-line Metastatic Squamous Non-small Cell Lung Cancer (NSCLC, MK-7339-008/KEYLYNK-008) |
| First Submitted : | June 3, 2019 |
| First Submitted that Met QC Criteria : | June 3, 2019 |
| First Posted : | June 6, 2019 |
| Last Update Submitted that Met QC Criteria : | January 8, 2021 |
| Last Update Posted : | January 11, 2021 |